Trial intelligence / Profile preview

Statins versus sertraline for depression after acute coronary syndrome

ChiCTR-IPR-14005672Phase 2Recruiting

Sponsor
Tongji Hospital
Start
Dec 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of rosuvastatin and sertraline in major depressive disorder (MDD) (3 arms), sponsored by Tongji Hospital. Primary endpoint: Degree of depression. Started Dec 2014; status: recruiting.

02

Drugs

rosuvastatinsertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on ChiCTR-IPR-14005672.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-14005672.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call